These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7473782)

  • 1. The effect of insulin and FFA on myocardial glucose uptake.
    Knuuti MJ; Mäki M; Yki-Järvinen H; Voipio-Pulkki LM; Härkönen R; Haaparanta M; Nuutila P
    J Mol Cell Cardiol; 1995 Jul; 27(7):1359-67. PubMed ID: 7473782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
    Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
    Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels.
    Monti LD; Lucignani G; Landoni C; Moresco RM; Piatti P; Stefani I; Pozza G; Fazio F
    Diabetes; 1995 May; 44(5):537-42. PubMed ID: 7729612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
    Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
    J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid.
    Mäki MT; Haaparanta M; Nuutila P; Oikonen V; Luotolahti M; Eskola O; Knuuti JM
    J Nucl Med; 1998 Aug; 39(8):1320-7. PubMed ID: 9708500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans.
    Nuutila P; Knuuti MJ; Raitakari M; Ruotsalainen U; Teräs M; Voipio-Pulkki LM; Haaparanta M; Solin O; Wegelius U; Yki-Järvinen H
    Am J Physiol; 1994 Dec; 267(6 Pt 1):E941-6. PubMed ID: 7810638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.
    Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM
    Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
    Turpeinen AK; Takala TO; Nuutila P; Axelin T; Luotolahti M; Haaparanta M; Bergman J; Hämäläinen H; Iida H; Mäki M; Uusitupa MI; Knuuti J
    Diabetes; 1999 Jun; 48(6):1245-50. PubMed ID: 10342811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog.
    Barrett EJ; Schwartz RG; Francis CK; Zaret BL
    J Clin Invest; 1984 Sep; 74(3):1073-9. PubMed ID: 6381537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A
    J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid uptake is preserved in chronically dysfunctional but viable myocardium.
    Mäki MT; Haaparanta MT; Luotolahti MS; Nuutila P; Voipio-Pulkki LM; Bergman JR; Solin OH; Knuuti JM
    Am J Physiol; 1997 Nov; 273(5):H2473-80. PubMed ID: 9374787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
    Choi Y; Brunken RC; Hawkins RA; Huang SC; Buxton DB; Hoh CK; Phelps ME; Schelbert HR
    Eur J Nucl Med; 1993 Apr; 20(4):308-18. PubMed ID: 8491223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.
    Bajaj M; Suraamornkul S; Kashyap S; Cusi K; Mandarino L; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4649-55. PubMed ID: 15356076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
    Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
    Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP.
    Kurata C; Wakabayashi Y; Shouda S; Mikami T; Takei Y; Tawarahara K; Sugiyama T; Nakano T; Fujisawa S; Andoh A
    J Nucl Med; 1997 Jul; 38(7):1079-84. PubMed ID: 9225794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
    Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
    J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acipimox does not augment thallium-201 redistribution in the fasting state.
    Gunning MG; Clunie G; Yepes-Mora S; Eastick S; Underwood SR; Bomanji J; Ell PJ
    J Nucl Cardiol; 1999; 6(6):620-5. PubMed ID: 10608589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.
    Nuutila P; Koivisto VA; Knuuti J; Ruotsalainen U; Teräs M; Haaparanta M; Bergman J; Solin O; Voipio-Pulkki LM; Wegelius U
    J Clin Invest; 1992 Jun; 89(6):1767-74. PubMed ID: 1601987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nicotinic acid on exogenous myocardial glucose utilization.
    Stone CK; Holden JE; Stanley W; Perlman SB
    J Nucl Med; 1995 Jun; 36(6):996-1002. PubMed ID: 7769458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in patients with cardiac hypertrophy.
    Paternostro G; Pagano D; Gnecchi-Ruscone T; Bonser RS; Camici PG
    Cardiovasc Res; 1999 Apr; 42(1):246-53. PubMed ID: 10435017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.